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Abstract
Objective—We reviewed a multi-institutional database to assess the effect of enteral feeding 
with human milk on duration from initiation of feeds to discharge after gastroschisis repair.
Study design—Infants who had gastroschisis repair between 1997 and 2012 with data recorded 
in the Pediatrix Medical Group Clinical Data Warehouse were categorized into 4 groups based on 
the percentage of days they were fed human milk out of the number of days they were fed 
enterally. Cox proportional hazards regression modeling was performed to determine the adjusted 
effect of human milk on duration from initiation of feeds to discharge.
Results—Of 3082 infants, 659 (21%) were fed human milk on 0% of enteral feeding days, 766 
(25%) on 1–50% of enteral feeding days, 725 (24%) on 51–99% of enteral feeding days, and 932 
(30%) on 100% of enteral feeding days. Following adjustment, being fed human milk on 0% of 
enteral feeding days was associated with a significantly increased time to discharge compared with 
being fed human milk on 100% of enteral feeding days (HR for discharge per day: 0.46, 95% CI: 
0.40–0.52). The same was found for infants fed human milk on 1–50% of enteral feeding days 
(HR: 0.37, 95% CI: 0.32–0.41) and for infants fed human milk on 51–99% of enteral feeding days 
(HR: 0.51, 95% CI: 0.46–0.57).
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Conclusion—The use of human milk for enteral feeding of infants following repair of 
gastroschisis significantly reduces the time to discharge from initiation of feeds.
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Multiple studies have demonstrated the benefits of human milk over formula for the 
newborn infant1,2; these include improved absorption of nutrients, immunological defenses, 
and maternal-infant bonding.3–5 Such benefits are of great importance in the preterm infant, 
who is at a much higher risk for a host of complications, including respiratory difficulties, 
infections, and in-hospital mortality.6,7 Human milk use is associated with a decreased 
incidence of necrotizing enterocolitis (NEC), a complication associated with substantial 
morbidity and mortality.8
Gastroschisis—a congenital defect in the para-umbilical abdominal wall associated with 
evisceration of abdominal organs—has a much higher incidence in preterm vs. full-term 
infants.9 Previous work has demonstrated that enteral feeding with human milk after 
gastroschisis repair is beneficial and may help prevent NEC10. However, additional benefits 
with regards to the use of human milk in these infants have not been explored fully. 
Therefore, we investigated the association of enteral feeding with human milk and time to 
discharge after gastroschisis repair, using time to discharge as a surrogate for the incidence 
of complications and the ability of the infant to tolerate feeds. We hypothesized that human 
milk use would be associated with reduced time to discharge.
Methods
The study population was drawn from an electronic medical record that prospectively 
captures information generated by clinicians on all infants cared for by the Pediatrix Medical 
Group in neonatal intensive care units (NICUs) in North America. This information includes 
data on multiple aspects of care taken from admission notes, daily progress notes, and 
discharge summaries and includes maternal history, demographics, medications, laboratory 
results, diagnoses, and procedures. The data are then transferred to the Pediatrix Clinical 
Data Warehouse for quality improvement and research purposes.11 Permission to conduct 
this analysis was provided by the Duke University Institutional Review Board.
We included infants if they had a report of gastroschisis in the diagnosis table between 1997 
and 2012. Infants were excluded if they did not receive human milk or formula at any point 
after gastroschisis repair, if they were discharged home on day of feeding 0 or 1, or if their 
postnatal age (PNA) at discharge was missing. Remaining infants were categorized a priori 
into 4 groups based on the percentage of days they received human milk out of their total 
days of enteral feeds: 0%, 1–50%, 51–99%, and 100%.
Definitions
We defined percentage of days fed as the percentage of days after gastroschisis repair during 
which infants received any amount of enteral nutrition. Percentage of human milk exposure 
was defined as the percentage of days fed during which an infant received any human milk. 
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Human milk included both mother’s human milk as well as donor human milk. Daily 
inotropic support was considered to be any exposure to amrinone, dobutamine, dopamine, 
epinephrine, milrinone, or norepinephrine on a given day. We characterized daily 
mechanical ventilation as any exposure to conventional or high-frequency ventilation on a 
given day. Percentage of days of inotropic and mechanical ventilator support was calculated 
as the number of days of inotropic or mechanical ventilator support after the first feed 
divided by the number of days from first feed until discharge. We determined a positive 
blood culture to be any blood culture positive for an organism not typically considered a 
contaminant obtained on a day after the first feed. We defined small for gestational age 
(SGA) as previously described.12
Statistical Analyses
Baseline characteristics and outcomes were compared between groups using standard 
summary statistics including median (25th, 75th percentile) and frequency (percentage). 
Continuous variables were compared with the Kruskal-Wallis test, and categorical variables 
were compared with Fisher exact test or chi-square tests of association as appropriate. We 
used Kaplan-Meier estimators, censoring infants lost to follow up and death, to determine 
the association of human milk and time from first enteral feed to discharge. Time to 
discharge among groups was compared using the log-rank test. Cox proportional hazards 
regression modeling was performed to determine the adjusted association between human 
milk use and time from first feed to discharge. Covariates included in the model were PNA 
at first feed, number of days the infant was not being fed after starting feeds, GA, SGA, 
percentage of days the infant was on inotropes, percentage of days the infant was on the 
ventilator, and any positive blood culture after feeds began. The proportional hazards 
assumption was tested using goodness-of-fit tests based on Schoenfeld residuals, and all 
potential covariates were inspected for linearity using visual inspection and goodness-of-fit 
tests. We also conducted a sensitivity analysis limited to infants who were discharged within 
3 weeks of their first feed to better ensure that our findings were not the result of unobserved 
confounding.
All statistical analyses were performed using Stata13.1 (College Station, TX). A p-value of 
0.05 was used to determine statistical significance.
Results
Of 3082 infants, 659 (21%) were fed human milk on 0% of enteral feeding days, 766 (25%) 
on 1–50% of enteral feeding days, 725 (24%) on 51–99% of enteral feeding days, and 932 
(30%) on 100% of enteral feeding days. On only 2.9% of feeding days was an infant fed 
both human milk and formula during 1 day. Infants in the 0% human milk group were more 
likely to be premature and African American (Table I). Infants fed 0% human milk were 
also significantly older on their first day of feeding compared with infants fed 100% human 
milk (median 13 days vs. 12 days, p<0.01).
Median (25th, 75th percentile) time from first feed to discharge was shorter in infants fed 
human milk on 100% of enteral feeding days as compared with those fed human milk on 
51–99%, 1–50%, and 0% of enteral feeding days (12 days [8, 17] vs. 19 days [13, 34] vs. 31 
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days [15, 60] vs. 20 days [11, 38], respectively, p<0.01). Compared with the other groups, 
infants fed 100% human milk also had significantly reduced rates of positive blood cultures 
and a reduced percentage of days on inotropes after beginning feeds (Table II). Lastly, 
infants who were fed 0% human milk had a significantly higher mortality than the other 
three groups.
After adjustment, infants fed 0% human milk continued to have a significantly prolonged 
length of stay following the start of enteral feeding compared with infants fed 100% human 
milk (adjusted hazard ratio [HR] for discharge per day: 0.46, 95% confidence interval [CI]: 
0.40, 0.52), as did infants fed human milk on 1–50% of feeding days (adjusted HR: 0.37, 
95% CI: 0.32, 0.41) and those fed human milk on 51–99% of feeding days (adjusted HR: 
0.51, 95% CI: 0.46, 0.57) (Figure). However, infants fed human milk on 1–50% of feeding 
days had a longer adjusted time to discharge than infants fed 0% human milk (adjusted HR: 
0.80, 95% CI: 0.71, 0.90).
In the sensitivity analysis, which grouped infants by percent enteral feed days the infant was 
fed human milk during the first 21 days of feeds, infants fed human milk on 0% of feeding 
days continued to have significantly increased time to discharge as compared with those fed 
human milk on 100% of feeding days (adjusted HR for discharge per day: 0.59, 95% CI: 
0.50, 0.69). The same was true for infants fed human milk on 1–50% of enteral feeding days 
(adjusted HR: 0.61, 95% CI: 0.52, 0.72) and those fed human milk on 51–99% of enteral 
feeding days (adjusted HR: 0.59, 95% CI: 0.52, 0.68).
Discussion
Gastroschisis is associated with a long hospital stay following surgical repair.13 Previous 
studies have demonstrated a beneficial effect in feeding these infants with human milk 
compared with formula after repair. However, these studies involved single-center 
retrospective reviews and were limited by small sample sizes.14 Using a database containing 
data from over 300 NICUs, we have demonstrated that feeding with human milk is 
associated with significantly decreased time to discharge following repair of gastroschisis, 
after adjusting for patient characteristics and other factors related to severity of illness.
It was important to adjust for patient factors, as at baseline, patients who received only 
human milk appeared to be less sick than those who received some enteral feeding days with 
only formula. This was supported by the finding that infants fed human milk were fed at an 
earlier postnatal age, as well as the finding that infants in the no human milk group had 
larger weight gains from birth to discharge. By adjusting for surrogates for severity of 
illness, including time to first feed as well as days on inotropes and days on the ventilator, 
we attempted to take this into account. Despite these baseline differences, after adjustment, 
we still found that the increasing utilization of human milk was associated with reduced time 
to discharge.
The use of time to discharge as our outcome of interest is important for many reasons. First, 
it acts as a composite for the real variables of interest, including the incidence of 
complications as well as the tolerability of enteral feeds. Second, time to discharge is also 
Gulack et al. Page 4
J Pediatr. Author manuscript; available in PMC 2017 March 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
related to hospital costs, an important concern in the current health care environment. Caring 
for infants in the NICU is expensive, especially for preterm and low-birth-weight infants.15 
Reductions in NICU length of stay by a day or two can result in large savings. Lastly, using 
time to discharge allowed us to perform an analysis that included censoring for death, which 
prevented bias from early mortality.
These findings are similar to those found in previous studies. Kohler et al performed a 
single-center study of 90 infants born with gastroschisis, and as in our study, separated them 
into 4 groups with 1 group receiving no human milk, 1 group receiving exclusively human 
milk, and the other 2 groups receiving mixed amounts of formula and human milk.14 The 
authors found on unadjusted analysis that the infants fed exclusively human milk had a 
significantly decreased time from initiation of feeds to full feeding. However, after adjusting 
for other factors, no significant difference between groups remained, likely due to the small 
sample size. We used a much larger sample size to show significant differences in time from 
feeding initiation to discharge between groups, even after adjustment for other factors. In 
this type of retrospective analysis, this adjustment is extremely important, as sicker children 
will be much less likely to continually tolerate feeds, making it much more difficult to keep 
a continuous supply of human milk on hand. Our ability to control for days during which an 
infant was not being fed helps decrease this risk of bias.
There are many reasons why human milk may be beneficial over formula in this population. 
Preterm infants are at extremely high risk for infections, and human milk contains important 
antibodies and other immunologic factors that may help decrease the incidence of these 
infections.3 Furthermore, it improves the absorption of vital nutrients and may be important 
for gastrointestinal health.4 Jayanthi et al performed a single-center review of their outcomes 
following repair of gastroschisis and found that, of 60 infants, 8 developed NEC.10 None of 
the infants who developed NEC had been fed exclusively human milk.
Although there was a clear benefit of being fed exclusively human milk or being fed human 
milk on 51–99% of feeding days over receiving no human milk, being fed human milk on 1–
50% of feeding days was associated with even longer time from initiation of feeds to 
discharge than being fed 0% human milk. This is likely due to incomplete adjustment for the 
infants’ severity of illness, as evidenced by the significantly higher number of days that 
infants in this group were not fed enterally after feeding initiation as compared with the 
other groups. Holding feeds after initiation may be a sign of poor tolerance but often is 
secondary to an underlying medical problem, and although we adjusted for the holding of 
feeds, we likely did not fully adjust for the underlying cause.
Our results demonstrated a significantly higher mortality among infants who were fed no 
human milk as compared with infants fed any amount of human milk. However, the inability 
to adjust for important characteristics such as the complexity of the gastroschisis must be 
taken into account. It is unclear whether mortality is associated directly with human milk or 
just a marker of more severe baseline disease in this patient population.
Although the results of our study are important for the care of the preterm infant following 
gastroschisis repair, there are limitations that should be acknowledged. First, as a 
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retrospective review of a multi-center database, there are missing variables that would assist 
in adjustment for patient-related factors, as the data were not collected specifically for this 
study. These include reasons for holding feeds, post-repair complications, reasons for not 
using human milk, methods of feeding, and fortification strategies. Second, although donor 
human milk can provide many of the same advantages as maternal human milk, it likely 
does not have the same magnitude of effect, and, unfortunately, we could not differentiate 
the two. Lastly, there may be other covariates that could not be adjusted for that may be 
partially responsible for the differences in outcomes between groups. For instance, 
socioeconomic status has been demonstrated to be associated with the use of human milk in 
newborn infants.16
In conclusion, after adjustment for patient characteristics and factors related to severity of 
illness, the use of human milk for enteral feeding of preterm infants following repair for 
gastroschisis significantly decreased the time from feeding initiation to discharge. This 
outcome is likely a surrogate for a reduction in post-repair complications and an 
improvement in tolerability of enteral feeding. Future research should focus on methods for 
increasing the use of human milk among these infants.
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Figure 1. 
Time to discharge by percent enteral feeding days on which the infant was given human 
milk. P < 0.01.
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